Published by Coherent Market Insights
Posted on September 14, 2021
Pachymetry is a quick and painless test that determines the thickness of the cornea. Corneal thickness, as measured by pachymetry, is important in the field of eye care for a number of reasons. Corneal thickness is critical in refractive surgery procedures such as LASIK (laser-assisted in-situ keratomileusis). It is necessary to understand corneal thickness in order to determine if a person is a candidate for laser vision correction. Pachymetry is also important in the treatment of glaucoma. Glaucoma is a condition in which the eye pressure (intraocular pressure) rises. Elevated eye pressure can result in nerve fiber loss in the retina, which can lead to blindness or reduced vision.
One type of pachymeter is known as optical pachymeters, and are designed to be mounted on a biomicroscope known as a slit lamp, which is used by eye doctors. This device has no direct contact with the cornea. OCT, or optical coherence tomography pachymetry, is a popular type of optical pachymetry.
Download Exclusive Sample Report @ https://www.coherentmarketinsights.com/insight/request-sample/4577
Market players and non-profit organizations are focused on raising awareness campaigns and initiatives, this could contribute to the growth of the global corneal pachymetry market over the forecast period. For instance on February 25, 2020, Allergan Inc., a subsidiary of AbbVie Inc., Sightsavers, an international non-governmental organization, and the International Agency for the Prevention of Blindness (IAPB), announced the launch of ‘Keep Sight India,’ a community-based glaucoma screening program designed to prevent glaucoma-related vision loss in Ganjam district, Odisha. The program trains healthcare professionals to screen at-risk populations, ensure early and accurate diagnosis, and provide appropriate treatment and long-term care in order to improve the lives of people with glaucoma at all levels of comprehensive eye care.
Market players are focusing on publishing the advantages of their medical devices in journals, which is expected to strengthen their position in the global corneal pachymetry market. For instance, on June 1, 2020, CSO, an International leader in diagnostic ophthalmic instruments, published about MS-39 AS-OCT, and how remarkably the device has performed in refractive surgeries. The MS-39 AS-OCT is the most sophisticated device for analyzing the anterior segment of the eye. It combines placido disk corneal topography with high resolution anterior segment tomography to provide information on corneal surface pachymetry, elevation, curvature, and dioptric power. Surgeons need several ocular metrics in refractive surgeries. Perhaps most importantly, one must rule out subclinical keratoconus (SCKCN) and ensure the absence of ocular surface disease (OSD); refractive surgeons spend a significant amount of time assessing and treating this prior to conducting a surgery. The MS-39 ASOCT has made a significant contribution in all of these functionalities.
Increasing applications of intraoperative optical computed tomography for corneal pachymetry in keratoconus patients is expected to drive the growth of the global corneal pachymetry market. For instance, according to the article published in July 2019, in the e-book ‘A Practical Guide to Clinical Application of OCT in Ophthalmology’, intraoperative optical coherence tomography (OCT) can be used to monitor corneal pachymetry during collagen cross-linking (CXL), a minimally invasive procedure that involves the use of ultraviolet light and eye drops to strengthen the collagen fibers in the cornea, in a safe and effective manner. The benefits of this technology includes providing a detailed profile of corneal thickness in a noncontact manner, which is especially beneficial for monitoring corneal pachymetry in the setting of CXL in keratoconus (KCN) patients when compared to the conventional ultrasound method. OCT has also been used to assess other aspects of the CXL procedure such as in vivo riboflavin penetration into the corneal stroma.
Buy This Complete A Business Report With Flat US $2000 Off @
https://www.coherentmarketinsights.com/promo/buynow/4577
Competitive Landscape
Major players operating in the global corneal pachymetry market include Micro Medical Devices, Inc. (MMD), Reichert, Inc. (AMETEK Inc.), OCULUS Optikgerate GmbH, Quantel Medical, Optovue Inc., DGH Technology, Inc., Escalon Medical Corp., Carl Zeiss AG, Keeler Ltd., and Konan Medical USA Inc.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
The post Impact of COVID-19 on Corneal Pachymetry Market Continues to Grow Rapidly as Collaborations within Market Players appeared first on Gatorledger.
Pachymetry is a quick and painless test that determines the thickness of the cornea. Corneal thickness, as measured by pachymetry, is important in the field of eye care for a number of reasons. Corneal thickness is critical in refractive surgery procedures such as LASIK (laser-assisted in-situ keratomileusis). It is necessary to understand corneal thickness in order to determine if a person is a candidate for laser vision correction. Pachymetry is also important in the treatment of glaucoma. Glaucoma is a condition in which the eye pressure (intraocular pressure) rises. Elevated eye pressure can result in nerve fiber loss in the retina, which can lead to blindness or reduced vision.
One type of pachymeter is known as optical pachymeters, and are designed to be mounted on a biomicroscope known as a slit lamp, which is used by eye doctors. This device has no direct contact with the cornea. OCT, or optical coherence tomography pachymetry, is a popular type of optical pachymetry.
Download Exclusive Sample Report @ https://www.coherentmarketinsights.com/insight/request-sample/4577
Market players and non-profit organizations are focused on raising awareness campaigns and initiatives, this could contribute to the growth of the global corneal pachymetry market over the forecast period. For instance on February 25, 2020, Allergan Inc., a subsidiary of AbbVie Inc., Sightsavers, an international non-governmental organization, and the International Agency for the Prevention of Blindness (IAPB), announced the launch of ‘Keep Sight India,’ a community-based glaucoma screening program designed to prevent glaucoma-related vision loss in Ganjam district, Odisha. The program trains healthcare professionals to screen at-risk populations, ensure early and accurate diagnosis, and provide appropriate treatment and long-term care in order to improve the lives of people with glaucoma at all levels of comprehensive eye care.
Market players are focusing on publishing the advantages of their medical devices in journals, which is expected to strengthen their position in the global corneal pachymetry market. For instance, on June 1, 2020, CSO, an International leader in diagnostic ophthalmic instruments, published about MS-39 AS-OCT, and how remarkably the device has performed in refractive surgeries. The MS-39 AS-OCT is the most sophisticated device for analyzing the anterior segment of the eye. It combines placido disk corneal topography with high resolution anterior segment tomography to provide information on corneal surface pachymetry, elevation, curvature, and dioptric power. Surgeons need several ocular metrics in refractive surgeries. Perhaps most importantly, one must rule out subclinical keratoconus (SCKCN) and ensure the absence of ocular surface disease (OSD); refractive surgeons spend a significant amount of time assessing and treating this prior to conducting a surgery. The MS-39 ASOCT has made a significant contribution in all of these functionalities.
Increasing applications of intraoperative optical computed tomography for corneal pachymetry in keratoconus patients is expected to drive the growth of the global corneal pachymetry market. For instance, according to the article published in July 2019, in the e-book ‘A Practical Guide to Clinical Application of OCT in Ophthalmology’, intraoperative optical coherence tomography (OCT) can be used to monitor corneal pachymetry during collagen cross-linking (CXL), a minimally invasive procedure that involves the use of ultraviolet light and eye drops to strengthen the collagen fibers in the cornea, in a safe and effective manner. The benefits of this technology includes providing a detailed profile of corneal thickness in a noncontact manner, which is especially beneficial for monitoring corneal pachymetry in the setting of CXL in keratoconus (KCN) patients when compared to the conventional ultrasound method. OCT has also been used to assess other aspects of the CXL procedure such as in vivo riboflavin penetration into the corneal stroma.
Buy This Complete A Business Report With Flat US $2000 Off @
https://www.coherentmarketinsights.com/promo/buynow/4577
Competitive Landscape
Major players operating in the global corneal pachymetry market include Micro Medical Devices, Inc. (MMD), Reichert, Inc. (AMETEK Inc.), OCULUS Optikgerate GmbH, Quantel Medical, Optovue Inc., DGH Technology, Inc., Escalon Medical Corp., Carl Zeiss AG, Keeler Ltd., and Konan Medical USA Inc.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
The post Impact of COVID-19 on Corneal Pachymetry Market Continues to Grow Rapidly as Collaborations within Market Players appeared first on Gatorledger.
